Sector Experience

Healthcare
Life Sciences & Pharma
Fortune 500

Experience

Independent Consultant Management Consulting
Independent Consultant
6/2018 - 11/2020
Leading clients in building tactics and strategies around product or service values

Therapeutic areas
CNS- Alzheimer’s disease, headache, major depressive disorder, multiple sclerosis, neuropathic pain, schizophrenia
Dermatologic- atopic dermatitis, psoriasis
Musculoskeletal- osteoarthritis, osteoporosis, psoriatic arthritis, rheumatoid arthritis
Oncology- renal cell carcinoma, prostate cancer, breast cancer, lymphomas
Rare conditions- angioedema, hemophilia, immune defici
Eli Lilly Management Consulting
Research Fellow/Strategy Scientist (for market access)
1/2016 - 5/2018
Activities were aligned with US Medical Affairs and Market Access for successful product launches. Used real-world evidence data and payer engagements to plan and execute clinical outcome metrics for value-based agreements in order to gain or maintain market access.
CSL Behring Corporate Strategy & Development
Senior Director and Head, Global Health Economics
1/2011 - 5/2015
Planned and executed value measurement and strategic market access activities for in-line compounds and compounds in development (Phases 1-3) for global application for acquired bleeding conditions, congenital bleeding conditions, critical care conditions, immune deficiencies, and acute coronary syndrome.
AstraZeneca Management Consulting
Senior Director, Medical Affairs, Field Economics Team
10/2009 - 1/2011
Led four field-based health economist liaisons who used their health economics and outcomes research and collaborative business skills to communicate and help confirm the value propositions of AstraZeneca branded products for new or continued market access for key US managed markets accounts.
Wyeth Research (Pfizer) Management Consulting
Senior Director, Global Health Outcomes Assessment
6/2001 - 10/2009
Shaped the direction for the differentiated value of new products developed for the use in humans in Phases 0-3 as neuroscience therapeutic area expert. Designed the collection of clinical and patient-reported outcomes. Led the dissemination of information which describes the value propositions of therapeutic entities from regulatory and marketplace perspectives in North America, Europe, and key nations along Pacific rim.